VEGFA and age-related macular degeneration: Moreover, the average number of intravitreal injections of anti-VEGF required in the AMD and PNV groups was estimated to be about 5 ± 1.7 and 3 ± 1.1, respectively, which was statistically significant (P < 0.02).